Key Takeaways
- Dimension Capital has launched an $800 million fund.
- The new fund is 60% larger than its previous $500 million fund.
- The firm focuses on investments at the intersection of science and technology.
- Notable investments include Chai Discovery and New Limit.
Fund Overview
Dimension Capital, a New York-based venture capital firm, has announced the launch of its third fund, totaling $800 million. This new fund represents a significant increase from the $500 million raised just 18 months ago. Founded in late 2022, the firm has quickly established itself in the competitive venture capital landscape.
Investment Strategy
Co-founders Zavain Dar, Adam Goulburn, and Nan Li have focused on investing in companies that blend biotechnology and software. Their initial belief was that there would be a growing demand for deep-tech companies, and they have been pleased with how rapidly this vision has materialized.
Noteworthy Investments
In 2024, Dimension Capital co-led a $30 million seed investment in Chai Discovery, a startup developing open-source AI models for drug development. Recently, Chai Discovery announced a $400 million funding round, bringing its valuation to $3.8 billion. Additionally, Dimension backed New Limit, an anti-aging startup co-founded by Coinbase CEO Brian Armstrong, which recently completed a Series C funding round at a valuation of $3.1 billion.
Portfolio Highlights
Other significant investments from Dimension include Modal Labs and Anthropic. The firm gained shares in Anthropic after the AI company acquired Coefficient Bio, a drug discovery platform that Dimension had previously invested in, for approximately $400 million.